Issue 2/2019
Content (27 Articles)
Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients
Alfredo Torres, Jeremy L. Ramdial, Luis E. Aguirre, Reshma Mahtani, Charles L. Vogel
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy
Maysa M. Abu-Khalaf, Anton Safonov, Jamie Stratton, Shiyi Wang, Christos Hatzis, Esther Park, Lajos Pusztai, Cary P. Gross, Raymond Russell
A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer
S. Speransky, P. Serafini, J. Caroli, S. Bicciato, M. E. Lippman, N. H. Bishopric
Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer
Chunyi Gao, Xiaoyu Yuan, Zhenglin Jiang, Deqiang Gan, Lingzhi Ding, Yechao Sun, Jiamin Zhou, Lihua Xu, Yifei Liu, Guohua Wang
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)
Jennifer R. Bellon, Hao Guo, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew Ellis, Antonio C. Wolff, Lisa A. Carey, Beth A. Overmoyer, Ann H. Partridge, Clifford A. Hudis, Ian Krop, Harold J. Burstein, Eric P. Winer, Sara M. Tolaney
Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery
George Boundouki, Joseph Ryan Wong Sik Hee, Natalie Croghan, Katie Stocking, Andrew Pieri, Adam Critchley, Cliona C. Kirwan, James R. Harvey
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases
Maria J. Sambade, Grace Prince, Allison M. Deal, Dimitri Trembath, Megan McKee, Amy Garrett, Kevin Keith, Juanita Ramirez, Bentley Midkiff, Kimberly Blackwell, Sarah Sammons, Jose Pablo Leone, Adam Brufsky, Aki Morikawa, Edi Brogi, Andrew Seidman, Matthew Ewend, Lisa A. Carey, Stergios J. Moschos, Ronald L. Hamilton, Benjamin Vincent, Carey Anders
Breast desmoid tumor management in France: toward a new strategy
Ludwig Duazo-Cassin, Sophie Le Guellec, Amélie Lusque, Elodie Chantalat, Marick Laé, Philippe Terrier, Jean-Michel Coindre, Bérénice Boulet, Morwenn Le Boulc’h, Dimitri Gangloff, Thomas Meresse, Benoit Chaput, Amal Al Ali, Françoise Rimareix, Sylvie Bonvalot, Charlotte Vaysse
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case–control analysis
Maoli Wang, Hongliang Chen, Kejin Wu, Ang Ding, Peng Zhang, Mingdi Zhang
The impact of communication style on patient satisfaction
Amelia A. Trant, Borbala Szekely, Sarah S. Mougalian, Michael P. DiGiovanna, Tara Sanft, Erin Hofstatter, Andrea Silber, Kerin B. Adelson, Anees Chagpar, Brigid Killelea, Nina Horowitz, Donald Lannin, Tristen Park, Michelle Corso, Gineesha Abraham, Karen Pollard-Murphy, Tracy Sturrock, Elspeth Knill-Selby, Ashley Western, Camille Servodidio, Marios Konstantinos Tasoulis, Barbara Healy, Christos Hatzis, Lajos Pusztai
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
Stephen. P. Ackland, V. Gebski, N. Zdenkowski, A. Wilson, M. Green, S. Tees, H. Dhillon, G. Van Hazel, J. Levi, R. J. Simes, J. F. Forbes, A. S. Coates
The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions
J. Beugels, J. L. W. Meijvogel, S. M. H. Tuinder, V. C. G. Tjan-Heijnen, E. M. Heuts, A. Piatkowski, R. R. W. J. van der Hulst
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
Ivana Sestak, Miguel Martín, Peter Dubsky, Ralf Kronenwett, Federico Rojo, Jack Cuzick, Martin Filipits, Amparo Ruiz, William Gradishar, Hatem Soliman, Lee Schwartzberg, Richard Buus, Dominik Hlauschek, Alvaro Rodríguez-Lescure, Michael Gnant
Circulating adipose stromal cells as a response biomarker in phase II energy balance trials of obese breast cancer survivors and high-risk women
Hailey A. Baker, Carol J. Fabian, Richard C. Hastings, Dan A. Dixon, Jennifer L. Nydegger, Teresa A. Phillips, Kandy R. Powers, Bruce F. Kimler
Establishing physical activity in breast cancer: self-report versus activity tracker
Chad W. Wagoner, Seul K. Choi, Allison M. Deal, Jordan T. Lee, William A. Wood, Hyman B. Muss, Kirsten A. Nyrop
Does every woman presenting with malignant calcifications require a post lumpectomy mammogram?
Hálio Rodrigues-Duarte, Thiemo J. A. van Nijnatten, Tatiana Khoury, Hiram Cody, Stefanie Jacobs, Maxine S. Jochelson
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa
Catherine Schairer, Ahmed Hablas, Ibrahim AbdelBar Seif Eldein, Rabab Gaafar, Henda Rais, Amel Mezlini, Farhat Ben Ayed, Wided Ben Ayoub, Abdellatif Benider, Ali Tahri, Mouna Khouchani, Dalia Aboulazm, Mehdi Karkouri, Saad Eissa, Ruth M. Pfeiffer, Shahinaz M. Gadalla, Sandra M. Swain, Sofia D. Merajver, Linda Morris Brown, Amr S. Soliman
Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study
Hak Min Lee, Bo Wook Kim, Seho Park, Sungmin Park, Jeon Eon Lee, Young Jin Choi, Sung Yong Kim, Sang Uk Woo, Hyun Jo Youn, Ilkyun Lee
Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
Leticia Varella, Akaolisa Samuel Eziokwu, Xuefei Jia, Megan Kruse, Halle C. F. Moore, George Thomas Budd, Jame Abraham, Alberto J. Montero
Evolution in practice patterns of axillary management following mastectomy in patients with 1–2 positive sentinel nodes
Anna Weiss, Heather Lin, Gildy V. Babiera, Isabelle Bedrosian, Simona F. Shaitelman, Yu Shen, Henry M. Kuerer, Elizabeth A. Mittendorf, Abigail S. Caudle, Kelly K. Hunt, Rosa F. Hwang
Shared-patient physician networks and their impact on the uptake of genomic testing in breast cancer
Jason Rotter, Lauren Wilson, Melissa A. Greiner, Craig E. Pollack, Michaela Dinan
Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients
Jung Youn Kim, Dae-Won Lee, Kyung-Hun Lee, Ahrum Min, Han Suk Ryu, Han-Byoel Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im, Sukil Kim
Racial disparities in surveillance mammography among older breast cancer survivors
Jimmitti Teysir, Nana Gegechkori, Juan P. Wisnivesky, Jenny J. Lin
Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists?
Constanze Elfgen, Giacomo Montagna, Seraina Margaretha Schmid, Walter Bierbauer, Uwe Güth
Classifying sarcopenia: using median value or cut-off values?
Onur Bas, Omer Dizdar
Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
Christoph J. Rageth, Elizabeth A. M. O’Flynn, Katja Pinker, Rahel A. Kubik-Huch, Alexander Mundinger, Thomas Decker, Christoph Tausch, Florian Dammann, Pascal A. Baltzer, Eva Maria Fallenberg, Maria P. Foschini, Sophie Dellas, Michael Knauer, Caroline Malhaire, Martin Sonnenschein, Andreas Boos, Elisabeth Morris, Zsuzsanna Varga